Skip to main content

Jessica Allegretti

Appearances

CP101, AN INVESTIGATIONAL ORALLY ADMINISTERED MICROBIOME THERAPEUTIC, WAS EFFECTIVE FOR PREVENTION OF RECURRENT C. DIFFICILE INFECTION: RESULTS FROM OPEN-LABEL PRISM-EXT TRIAL
Date
May 23, 2022
Speaker
Jessica Allegretti
IBD
Date
May 6, 2023
Speakers
Maria T. Abreu
Cedars-Sinai Medical Center
Ryan Ungaro
Edward Loftus
Mayo Foundation for Medical Education and Research
Jessica Allegretti